Market Price

179.00 

-6.20 -3.4%

as of May 20 '20

52 Week Range:

132.20 250.00


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Virbac SA produces and sells medicines and vaccines for companion and food-producing animals in France and internationally. The company offers Boviseal, a suspension to prevent intramammary infections; Bovigen Scour, a vaccine used to protect calves against viral and bacterial infections; C.E.T. Veggiedent Fr3sh to treat oral and digestive causes of bad breath; Canigen vaccines; Clostrisan, a vaccine for the prevention of clostridiosis and botulism; Effipro bovis to treat tick, flea, and louse infestations; Epiotic, an ear cleanser; and Eradia to treat clostridium infections and giardiasis. It also provides Fosfosal, a trace mineral injectable supplementation; Grofactor, a growth promoter; Inflacalm, a multi-species anti-inflammatory; Iverhart Max Soft Chew, a chewable tablets to prevent heartworm disease; Milpro, an internal parasiticide tablets; Moxiheart, an internal parasiticide; and Multimin, a trace element injectable supplement. In addition, the company offers Suigen PCV2, a vaccine against porcine circovirus; Penclox, an antibiotic lactating intramammary targeting common bacteria causing mastitis; Physiological eye cleanser, an isotonic solution for cleaning the eye and surrounding areas; Porcistart, a feed supplement; Propofol, an anesthetic; Quadrant to treat infections; and Rabigen mono, a rabies vaccine. Further, it provides Rilexine to treat skin and urinary infections; Sentinel Flavor Tabs and Sentinel Spectrum; Shotapen for bacterial infections; Suigen PCV2, a vaccine for porcine circovirus; Suprelorin, a deslorelin-based implant for the induction of temporary infertility; Tribrissen, a parasiticide oral solution; Ultra-corn used to stimulate the immune system; Veterin, an antibiotic; Veterinary HPM, a specialized petfood; Virbagest, an altrenogest-based progestin; Virbagen Omega, a veterinary interferon; Zenifel, a fogger and spray; and Zoletil, a multi-species general anesthetic. Virbac SA was founded in 1968 and is headquartered in Carros, France.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Equity (BVPS) 26.81
34.59
36.46
41.11
41.63
44.91
51.09
52.56
56.04
53.45
57.98
growth rate 29.0% 5.4% 12.8% 1.3% 7.9% 13.8% 2.9% 6.6% -4.6% 8.5%
Earnings BIT 56.36
86.13
83.50
95.46
105.44
109.57
38.88
66.32
64.93
75.03
104.82
growth rate 52.8% -3.1% 14.3% 10.5% 3.9% -64.5% 70.6% -2.1% 15.6% 39.7%
Avg.PE 16.26
17.76
17.54
18.94
21.65
35.58
44.98
54.00
28.43
28.43
24.12
growth rate 9.2% -1.2% 8.0% 14.3% 64.3% 26.4% 20.1% -47.4% 0.0% -15.2%
ROA 9.16
13.10
10.25
9.41
7.02
5.72
0.68
2.43
-0.19
1.58
3.97
growth rate 43.0% -21.8% -8.2% -25.4% -18.5% -88.1% 257.4% -100.0% 100.0% 151.3%
ROE 17.97
23.77
18.81
20.26
17.12
16.06
2.16
7.60
-0.57
4.48
10.54
growth rate 32.3% -20.9% 7.7% -15.5% -6.2% -86.6% 251.9% -100.0% 100.0% 135.3%
ROIC 17.97
20.46
19.44
13.65
11.75
8.57
1.71
4.38
1.06
3.30
6.53
growth rate 13.9% -5.0% -29.8% -13.9% -27.1% -80.1% 156.1% -75.8% 211.3% 97.9%
Cur. Ratio 1.38
1.48
1.43
1.37
1.43
1.34
1.33
1.10
1.22
1.23
1.21
growth rate 7.3% -3.4% -4.2% 4.4% -6.3% -0.8% -17.3% 10.9% 0.8% -1.6%
Quick Ratio 0.30
0.90
0.81
0.69
0.71
0.98
0.67
0.49
0.54
0.53
0.55
growth rate 200.0% -10.0% -14.8% 2.9% 38.0% -31.6% -26.9% 10.2% -1.9% 3.8%
Leverage 1.86
1.78
1.89
2.39
2.48
3.08
3.26
2.99
2.93
2.77
2.56
growth rate -4.3% 6.2% 26.5% 3.8% 24.2% 5.8% -8.3% -2.0% -5.5% -7.6%
Balance Sheet Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Acct.Receivable 75.00
107.00
116.00
145.00
170.74
204.28
239.69
178.37
158.14
140.87
140.82
growth rate 42.7% 8.4% 25.0% 17.8% 19.6% 17.3% -25.6% -11.3% -10.9% 0.0%
Acct.Payable 72.00
62.00
74.00
77.65
82.98
114.78
99.13
105.67
86.80
90.07
growth rate -13.9% 19.4% 4.9% 6.9% 38.3% -13.6% 6.6% -17.9% 3.8%
Cur.Assets 186.30
253.00
259.00
324.00
351.09
750.80
485.50
433.51
400.60
407.55
450.87
growth rate 35.8% 2.4% 25.1% 8.4% 113.9% -35.3% -10.7% -7.6% 1.7% 10.6%
Total Assets 434.50
534.00
589.00
828.00
896.23
1,325.84
1,430.55
1,417.16
1,277.31
1,272.81
1,323.26
growth rate 22.9% 10.3% 40.6% 8.2% 47.9% 7.9% -0.9% -9.9% -0.4% 4.0%
Cash 14.10
40.00
24.00
40.00
34.97
375.91
51.16
48.45
48.38
62.81
93.66
growth rate 183.7% -40.0% 66.7% -12.6% 974.9% -86.4% -5.3% -0.2% 29.8% 49.1%
Inventory 70.60
99.00
112.00
132.00
138.78
159.87
182.31
197.91
184.76
195.78
206.58
growth rate 40.2% 13.1% 17.9% 5.1% 15.2% 14.0% 8.6% -6.6% 6.0% 5.5%
Cur.Liabilities 135.30
170.00
181.00
236.00
244.89
557.70
364.08
393.10
328.50
331.27
372.49
growth rate 25.7% 6.5% 30.4% 3.8% 127.7% -34.7% 8.0% -16.4% 0.8% 12.5%
Liabilities 200.90
231.00
275.00
429.00
481.86
843.65
948.26
896.37
798.49
776.93
771.38
growth rate 15.0% 19.1% 56.0% 12.3% 75.1% 12.4% -5.5% -10.9% -2.7% -0.7%
LT Debt 34.50
32.00
71.00
146.00
179.80
221.69
518.56
433.14
408.26
374.28
306.86
growth rate -7.3% 121.9% 105.6% 23.2% 23.3% 133.9% -16.5% -5.7% -8.3% -18.0%
Equity 236.20
302.40
313.90
398.40
360.93
431.34
438.41
473.63
436.33
460.31
517.78
growth rate 28.0% 3.8% 26.9% -9.4% 19.5% 1.6% 8.0% -7.9% 5.5% 12.5%
Common Shares 9.00
9.00
8.00
8.00
8.00
8.00
8.00
8.00
8.00
8.00
8.00
growth rate 0.0% -11.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Capital Expenditures 19.80
22.00
38.00
29.00
54.80
35.69
37.02
34.38
31.54
25.82
16.72
growth rate 11.1% 72.7% -23.7% 89.0% -34.9% 3.7% -7.1% -8.3% -18.1% -35.3%
Cash Dividends 10.40
11.40
13.00
14.70
16.02
16.01
16.01
growth rate 9.6% 14.0% 13.1% 9.0% 0.0% 0.0%
Cash From OA 64.80
84.00
62.00
97.00
73.63
76.45
46.22
142.45
107.81
83.62
131.61
growth rate 29.6% -26.2% 56.5% -24.1% 3.8% -39.5% 208.2% -24.3% -22.4% 57.4%
FCF per Share 4.91
6.80
2.02
7.26
1.32
3.26
3.91
6.38
9.36
7.81
9.05
growth rate 38.5% -70.3% 259.4% -81.8% 147.0% 19.9% 63.2% 46.7% -16.6% 15.9%
Sale Purchase of Stock 0.51
0.51
0.05
growth rate 0.0% -90.4%
FCF 43.00
59.00
18.00
61.00
14.00
36.00
4.00
102.00
70.00
50.00
109.00
growth rate 37.2% -69.5% 238.9% -77.1% 157.1% -88.9% 2,450.0% -31.4% -28.6% 118.0%
Income Statement Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Sales 467.40
573.00
623.00
695.00
736.08
773.12
852.62
871.83
861.88
868.93
938.34
growth rate 22.6% 8.7% 11.6% 5.9% 5.0% 10.3% 2.3% -1.1% 0.8% 8.0%
Op.Income 58.30
64.00
59.00
67.00
105.44
109.57
38.88
66.32
64.93
75.03
104.82
growth rate 9.8% -7.8% 13.6% 57.4% 3.9% -64.5% 70.6% -2.1% 15.6% 39.7%
IBT 56.40
86.10
83.50
95.50
94.73
99.68
14.61
52.85
41.00
41.35
77.86
growth rate 52.7% -3.0% 14.4% -0.8% 5.2% -85.4% 261.9% -22.4% 0.9% 88.3%
Net Income 39.70
64.00
59.00
67.00
60.52
63.60
9.41
34.65
-2.58
20.10
51.55
growth rate 61.2% -7.8% 13.6% -9.7% 5.1% -85.2% 268.4% -100.0% 100.0% 156.5%
EPS 4.48
7.32
6.83
7.91
7.18
7.54
1.12
4.11
-0.31
2.39
6.11
growth rate 63.4% -6.7% 15.8% -9.2% 5.0% -85.2% 267.0% -100.0% 100.0% 155.7%
Gross Profit 315.90
391.00
428.00
480.00
504.66
528.51
554.77
571.68
558.44
574.64
623.54
growth rate 23.8% 9.5% 12.2% 5.1% 4.7% 5.0% 3.1% -2.3% 2.9% 8.5%

Quarterly Statements

Item Name Dec '18 Mar '19 Jun '19 Sep '19 Dec '19
Earnings BIT 18.76
28.70
28.70
23.72
23.72
growth rate 53.0% 0.0% -17.4% 0.0%
Balance Sheet Dec '18 Mar '19 Jun '19 Sep '19 Dec '19
Acct.Receivable 140.87
156.86
156.86
140.82
140.82
growth rate 11.4% 0.0% -10.2% 0.0%
Acct.Payable 86.80
82.34
82.34
90.07
90.07
growth rate -5.1% 0.0% 9.4% 0.0%
Cur.Assets 407.55
447.18
447.18
450.87
450.87
growth rate 9.7% 0.0% 0.8% 0.0%
Total Assets 1,272.81
1,325.02
1,325.02
1,323.26
1,323.26
growth rate 4.1% 0.0% -0.1% 0.0%
Cash 62.81
70.87
70.87
93.66
93.66
growth rate 12.8% 0.0% 32.2% 0.0%
Inventory 195.78
208.86
208.86
206.58
206.58
growth rate 6.7% 0.0% -1.1% 0.0%
Cur.Liabilities 331.27
307.14
307.14
372.49
372.49
growth rate -7.3% 0.0% 21.3% 0.0%
Liabilities 776.93
799.80
799.80
771.38
771.38
growth rate 2.9% 0.0% -3.6% 0.0%
LT Debt 374.28
398.74
398.74
306.86
306.86
growth rate 6.5% 0.0% -23.0% 0.0%
Equity 460.31
488.90
488.90
517.78
517.78
growth rate 6.2% 0.0% 5.9% 0.0%
Common Shares 10.57
10.57
10.57
10.57
10.57
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '18 Mar '19 Jun '19 Sep '19 Dec '19
Capital Expenditures 6.34
3.83
3.83
4.53
4.53
growth rate -39.6% 0.0% 18.5% 0.0%
Cash Dividends
growth rate
Cash From OA 41.05
11.77
11.77
54.03
54.03
growth rate -71.3% 0.0% 359.0% 0.0%
Sale Purchase of Stock
growth rate
FCF 34.71
7.95
7.95
49.50
49.50
growth rate -77.1% 0.0% 522.9% 0.0%
Income Statement Dec '18 Mar '19 Jun '19 Sep '19 Dec '19
Sales 219.49
231.87
231.87
237.30
237.30
growth rate 5.6% 0.0% 2.4% 0.0%
Op.Income 18.76
28.70
28.70
23.72
23.72
growth rate 53.0% 0.0% -17.4% 0.0%
IBT 8.34
20.68
20.68
18.25
18.25
growth rate 147.9% 0.0% -11.8% 0.0%
Net Income 3.92
13.22
13.22
12.56
12.56
growth rate 237.6% 0.0% -5.0% 0.0%
Gross Profit 144.83
155.62
155.62
156.15
156.15
growth rate 7.5% 0.0% 0.3% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (56.39)

YOY Growth Grade:

E (31.63)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 30.25 29.30 19.04
EPS / Growth -19.6% 6.11 13.8%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 6.3%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.0% 3.7% 3.7%
Future PE 2.00 18.87 18.87
Future EPS 6.75 8.75 8.75
Value Price
MOS %
3.34
-98.1%
40.82
-77.2%
40.82
-77.2%
MOS Price 1.67 20.41 20.41
IRT 25.59 19.75 19.75

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.